| Marjorie R Sharkey, LCSWC | |
|
10435 Downsville Pike, Hagerstown, MD 21740-1732 | |
| (301) 766-2800 | |
| Not Available |
| Full Name | Marjorie R Sharkey |
|---|---|
| Gender | Female |
| Speciality | Social Worker - Clinical |
| Location | 10435 Downsville Pike, Hagerstown, Maryland |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1295063899 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 1041C0700X | Social Worker - Clinical | 15565 (Maryland) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Marjorie R Sharkey, LCSWC 10435 Downsville Pike, Hagerstown, MD 21740-1732 Ph: (301) 722-2800 | Marjorie R Sharkey, LCSWC 10435 Downsville Pike, Hagerstown, MD 21740-1732 Ph: (301) 766-2800 |
News Archive
The active agent ziconotide, the synthetic toxin of the cone snail (Conus magus), was acclaimed a safe alternative to morphine when it was introduced six years ago. Now it is increasingly suspected of causing patients to commit suicide.
News outlets report on how the exchanges are working and how consumers are responding in Pennsylvania, Florida, Mississippi, Hawaii, Minnesota and California.
Decision Resources, one of the world's leading research and advisory firms for pharmaceutical and healthcare issues, finds that, based on clinical profiles provided to them, surveyed clinicians estimate that one year after the launch of Vertex Pharmaceuticals/Johnson & Johnson/Mitsubishi Tanabe Pharma's telaprevir and Merck's boceprevir, at least 90 percent of hepatitis C virus patients will be treated with triple therapy regimens.
Exelixis, Inc. today announced that the U.S. Food & Drug Administration (FDA) has granted orphan drug designation to XL184 for treatment of follicular, medullary, and anaplastic thyroid carcinoma, and metastatic or locally advanced papillary thyroid cancer. A pivotal phase 3 trial of XL184 is ongoing in patients with medullary thyroid cancer (MTC) and the company expects to release top-line phase 3 results in the first-half of 2011 and potentially file a New Drug Application (NDA) for the compound in the second-half of 2011.
› Verified 6 days ago
Annette Jeffers, LCSW-C Clinical Social Worker Medicare: Not Enrolled in Medicare Practice Location: 370 Virginia Ave, Hagerstown, MD 21740 Phone: 301-733-3130 | |
Victoria Leizer, Clinical Social Worker Medicare: Not Enrolled in Medicare Practice Location: 5 Public Sq # 428, Hagerstown, MD 21740 Phone: 301-514-3960 | |
Vicki S Churchey, LCSW Clinical Social Worker Medicare: Accepting Medicare Assignments Practice Location: 18714 N Village, Hagerstown, MD 21742 Phone: 301-733-0330 Fax: 301-733-4038 | |
Ms. Patti Kay Cooper, LCSW-C Clinical Social Worker Medicare: Not Enrolled in Medicare Practice Location: 11116 Medical Campus Rd, Suite 2989, Hagerstown, MD 21742 Phone: 301-766-7600 Fax: 301-766-7702 | |
Tammy Sherrard, LCSW-C Clinical Social Worker Medicare: Accepting Medicare Assignments Practice Location: 1180 Professional Ct, Hagerstown, MD 21740 Phone: 301-791-3045 Fax: 240-313-3071 | |
Mr. Edward John Soffe, LCSW-C Clinical Social Worker Medicare: Not Enrolled in Medicare Practice Location: 113 S Prospect St, Hagerstown, MD 21740 Phone: 301-573-2800 | |
Desirae Mehaffie, LCSWC Clinical Social Worker Medicare: Medicare Enrolled Practice Location: 1180 Professional Ct, Hagerstown, MD 21740 Phone: 301-791-3045 Fax: 240-313-3071 |